9 Results for "

FHIT

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "FHIT" in MCE Product Catalog:

  • Isoforms Recommended:
Cat. No.: HY-RS04933
Research Areas:  

Others

FHIT Human Pre-designed siRNA Set A contains three designed siRNAs for FHIT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS19329
Research Areas:  

Others

Fhit Mouse Pre-designed siRNA Set A contains three designed siRNAs for Fhit gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-158845
CAS No.: 2937864-01-0
Target:  

Apoptosis

Research Areas:  

Cancer

8Br-HA is a potent FHIT inhibitor with an IC50 of 0.12 μM. 8 BR-HA can induceApoptosis. 8Br-HA has antitumor activity .
loading...
    loading...
Cat. No.: HY-RS25820
Research Areas:  

Others

Fhit Rat Pre-designed siRNA Set A contains three designed siRNAs for Fhit gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P75187
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Bis(5'-adenosyl)-triphosphatase; AP3A hydrolase; AP3Aase; FHIT
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P810873
Synonyms: Endonuclease G mitochondrial; Endo G

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P82932
Synonyms: AP3A hydrolase; AP3Aase; Dinucleosidetriphosphatase; FRA3B

Host:  

Rabbit

Application:  

WB

Reactivity:  

Human, Rat

loading...
    loading...
Cat. No.: HY-L077
4,249 compounds

Pancreatic cancer is a devastating disease with a low overall survival rate. Chemotherapy is the most common treatment for patients presenting with advanced pancreatic cancer. More recently, the era of targeted therapies has generated a lot of interest in discovering better approaches for patients with pancreatic cancer. Commonly mutated genes in pancreatic cancer include K-ras (in 74-100% of cases), p16INK4a (up to 98%), p53 (43 to 76%), DPC4 (about 50%), HER-2/neu (in about 65%) and FHIT (found in 70% of cases). Other genes involved are notch1, Akt-2, BRCA2 and COX-2. These proteins are important targets of target therapies for pancreatic cancer.

MCE offers a unique collection of 4,249 compounds with identified and potential anti- pancreatic cancer activity. These compounds target K-Ras, p53, HER2, Notch, AKT, etc. MCE anti-pancreatic cancer compound library is a useful tool for anti-pancreatic cancer drugs screening and other related research.

Cat. No.: HY-P811178
Synonyms: KIAA0651; LFP40; Rho guanine nucleotide exchange factor 2; Guanine nucleotide exchange factor H1; GEF-H1; Microtubule-regulated Rho-GEF; Proliferating cell nucleolar antigen p40

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF

Reactivity:  

Human, Mouse

loading...
    loading...